In Jakarta, There Are 55 Cases Of The Delta Variant That Transmit COVID-19 4 Times Faster Kali

JAKARTA - Head of the Disease Prevention and Control Division of the DKI Health Office, Dwi Oktavia, said that currently there are 55 new cases of the Delta type of COVID-19 variant in the capital.

The Delta variant is a COVID-19 mutation originating from India. From the results of the study, the Delta variant was proven to be 4 times more infectious and increased hospitalization rates.

Dwi said that the findings of this virus mutation came from the examination of whole genome sequencing (WGS) of 987 samples of cases of suspected virus mutations. In total, there are 70 samples that are declared as new variants or variants of concern (VoC).

"There are details for the 70 VoCs, namely 12 Alpha variants or B117, 3 Beta variants or B1351 and 55 Delta B1617.2 variants," said Dwi in his statement, Thursday, June 24.

Of the 70 cases of the new variant, it has been identified that 33 cases have a history of travel from abroad, 19 local transmissions of the Delta variant in DKI Jakarta, 10 local transmissions of the Delta variant in Bodetabek where the examination was carried out in Jakarta.

"Then, 8 cases are still in the verification process whether they are Delta variants from abroad or local transmissions," said Dwi.

Regarding the new variant of the COVID-19 virus mutation, Dwi appealed to the entire community to remain vigilant because this new variant spreads more quickly and causes more severe symptoms.

The way, said Dwi, is to follow a vaccination program accompanied by strict health protocols. This can minimize the potential for contracting the corona virus.

"It should also be noted that all current vaccine brands are effective in preventing new virus mutation variants. All vaccine brands are safe, useful, and of high quality. Vaccination is proven not only to prevent illness, but also to prevent death. this," he said.

It is known, the total number of vaccination targets for DKI Jakarta Province is 8,815,157 people. For program vaccination, the current total dose 1 is 3,753,451 people, 43 percent and the total dose 2 now reaches 1,898,567 people, 22 percent.